My Watchlist
Indicators
EL&P Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Zepbound copycats remain online despite FDA ban
Tags Business News Business Novo Nordisk A/S
From CNBC.com News
Healthy Returns: Wegovy is linked to an increased risk of hair loss, study suggests
Tags Biotech and Pharmaceuticals Healthy Returns Social issues
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Economy Investment strategy Markets
From CNBC.com News
Novo Nordisk shares fall 5.5% after latest trial results for its next-generation weight loss drug
Tags Breaking News: Europe Breaking News: Markets Novo Nordisk A/S
From CNBC.com News
Amgen starts two critical late-stage trials for weight loss drug MariTide
Tags Business Biotechnology Novo Nordisk A/S
From CNBC.com News
Novo Nordisk offers Wegovy for less than half the price through new direct-to-consumer pharmacy
Tags Breaking News: Business Novo Nordisk A/S Biotechnology
From CNBC.com News
Healthy Returns: AbbVie is the newest potential weight loss drug market player
Tags Biotech and Pharmaceuticals Social issues Healthy Returns
From CNBC.com News
Eli Lilly plans at least $27 billion in new U.S. manufacturing investments
Tags Health care industry Health & Science Companies
From CNBC.com News
Shortage of Novo Nordisk's Wegovy and Ozempic drugs is resolved, FDA says
Tags LILLY DRN Biotech and Pharmaceuticals Business News
From CNBC.com News
Cramer's Lightning Round: Sunoco is a buy
Tags Investment Strategy Stock markets Mad Money
From CNBC.com News
Healthy Returns: Ozempic helps curb alcohol use in new study — and doctors are concerned about telehealth GLP-1s
Tags Health care industry Health & Science Novo Nordisk A/S
From CNBC.com News
Trump's reciprocal tariffs would hit these European Union products that Americans buy the hardest
Tags World economy Ford Motor Co Volvo AB
From CNBC.com News
Trump is unlikely to end Medicare drug price talks — here's what that means for patients and pharma
Tags Health care industry Health & Science Companies
From CNBC.com News
Hims & Hers faces scrutiny from lawmakers over 'misleading' Super Bowl ad
Tags Breaking News: Technology Health & Science Health care industry
From CNBC.com News
Eli Lilly to release late-stage data on next-generation weight loss drug retatrutide in 2025, earlier than expected
Tags Pharmaceuticals US: News Health care industry
From CNBC.com News
Novo Nordisk CEO says he's confident about Wegovy supply, next-generation weight loss drugs
Tags Biotech and Pharmaceuticals Earnings Novo Nordisk A/S
From CNBC.com News
Novo Nordisk posts net profit beat as Wegovy sales jump 107% in fourth quarter
Tags Breaking News: Europe Novo Nordisk A/S Earnings
From CNBC.com News
Healthy Returns: Why people quit weight loss, diabetes drugs within one year
Tags Health care industry Health & Science Novo Nordisk A/S
From CNBC.com News
Jim Cramer's week ahead: Earnings from Amazon, Alphabet, Eli Lilly, Palantir
Tags LILLY DRN Novo Nordisk A/S Business News
From CNBC.com News
FDA approves Novo Nordisk’s diabetes drug Ozempic for chronic kidney disease, expanding its use
Tags US: News Pharmaceuticals Health & Science
From CNBC.com News
World's largest luxury group LVMH posts better than feared full-year sales
Tags Compagnie Financiere Richemont SA Hennessy Advisors Inc LVMH Moet Hennessy Louis Vuitton SE
From CNBC.com News
Food-as-medicine startups hope Kennedy, if confirmed as HHS secretary, will boost their businesses
Tags Social issues Venture capital Nutrition
From CNBC.com News
Novo Nordisk shares pop 10% on early-stage weight loss drug trial results
Tags Pharmaceuticals Biotech and Pharmaceuticals Biotechnology
From CNBC.com News
Healthy Returns: Biotech and pharma M&A is off to a good start in 2025 — but will it last?
Tags Healthy Returns Social issues Biotech and Pharmaceuticals
From CNBC.com News
'Miracle' drug innovation could see a new Wegovy launch every couple of years, Larry Summer says
Tags Biotech and Pharmaceuticals World Economy Pharmaceuticals
From CNBC.com News
GLP-1s and Brian Thompson’s killing loom large at top health-care conference
Tags LILLY DRN Walgreens Boots Alliance Inc Cigna Corp
From CNBC.com News
Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications
Tags Biotech and Pharmaceuticals AstraZeneca PLC Abbvie Inc
From CNBC.com News
Eli Lilly CEO expects new weight loss pill to be approved next year
Tags Health & Science Health care industry Business News
From CNBC.com News
High-cost weight loss drugs are sending employers to nutrition counseling in a boost for startups
Tags Pharmaceuticals LILLY DRN Zillow Group Inc
From CNBC.com News
Medicare can now cover Eli Lilly’s Zepbound for sleep apnea, CMS says
Tags LILLY DRN Biotech and Pharmaceuticals Social issues
From CNBC.com News
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.